Peak Asset Management LLC Buys New Stake in Cigna Group $CI

Peak Asset Management LLC bought a new position in shares of Cigna Group (NYSE:CI) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,895 shares of the health services provider’s stock, valued at approximately $522,000.

Several other hedge funds also recently added to or reduced their stakes in CI. Fiduciary Financial Advisors acquired a new position in Cigna Group during the second quarter worth approximately $29,000. Manning & Napier Advisors LLC purchased a new stake in Cigna Group in the 2nd quarter valued at $6,062,000. Cetera Trust Company N.A acquired a new stake in Cigna Group during the 2nd quarter worth $111,000. Paradigm Capital Management Inc. NY purchased a new position in Cigna Group during the 2nd quarter worth $496,000. Finally, Aberdeen Wealth Management LLC acquired a new position in Cigna Group in the second quarter valued at $776,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 23,012 shares of company stock worth $6,386,550. 0.60% of the stock is owned by company insiders.

Cigna Group Trading Up 1.0%

Shares of CI stock opened at $280.32 on Tuesday. The stock has a market cap of $74.07 billion, a P/E ratio of 11.60, a P/E/G ratio of 0.95 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The business has a fifty day simple moving average of $283.92 and a 200-day simple moving average of $281.48.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. UBS Group boosted their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Morgan Stanley upped their price target on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Wells Fargo & Company lifted their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.